RevolKa Ltd. Partners with La Jolla Institute for Immunology to Develop Next-Generation Vaccines

RevolKa Ltd. partners with La Jolla Institute for Immunology to develop next-generation vaccines using innovative protein engineering technology aiProtein. This collaboration aims to address unmet medical needs in infectious diseases, marking a significant step towards advancing vaccine research and development.